August - December 2018
April - August 2018
September- November 2017
December 2017 - April 2018
BeiGene’s Phase III BGB-3111 in WM Has Unclear Efficacy Advantage Over Imbruvica
Corbus’ Phase II Anabasum in Dermatomyositis Garners Mixed Expert Expectations